Summary
Companion OMB memo that rescinds M-24-18 and sets standards for federal agencies to acquire AI responsibly, emphasizing competition in the AI marketplace, lifecycle risk management, performance monitoring, and safeguards for privacy and civil rights in AI contracts.
Healthcare Implications
Shapes how federal health agencies and programs procure AI-enabled clinical, analytic, and administrative tools by requiring acquisition processes that incorporate AI risk assessment, privacy and civil-rights protections, performance monitoring, and vendor accountability into contracts for health-related AI systems.